ABOUT Biosyntech was established in 2019, the founder has more than 15 years marketing experience for the regulated market, like China, US, EU, Korea, Japan and so on. Biosyntech is a platform to support our clients with Qualified Generic APIs, which can meet our clients’ registration and commercial purpose. Meanwhile Biosyntech has an experienced R&D team to handle custom synthesis requirement from the markets, like Pharma regulatory starting material, novel building blocks, and Intermediates, the quantity can be from mg to tons.